Nigeria’s Quiet Pandemic: The Deadly Rise of Colon Cancer in Youth

LAGOS — Once considered a disease of the elderly, colorectal cancer (CRC) has taken a predatory turn in Nigeria, rapidly emerging as a “quiet pandemic” among the nation’s youth. Medical experts are now sounding the alarm as a growing number of patients in their 20s and 30s present with advanced stages of the disease, driven by a lethal cocktail of “Westernized” diets, sedentary lifestyles, and a critical lack of early screening.

​Historically, colorectal cancer—which affects the large intestine or rectum—was typically diagnosed in patients aged 60 and above. However, the demographic landscape has shifted.

​”In Nigeria, there has been a clear shift,” says Dr. Ganiyat Oyeleke, a Consultant Gastroenterologist at Gastroderm Clinic. “A substantial proportion of patients now fall within the 30–50 age group, and we are seeing cases in their early 20s. It is no longer a disease limited to the elderly.”

​Dr. Eben Aje, a Consultant Radiation Oncologist at the Medserve LUTH Cancer Centre, describes the trend in even starker terms. “It is becoming something of a pandemic. We are seeing a surge that demands immediate national attention.”

​The “Western” Trigger and the Charred Danger

​The primary culprit, according to specialists, is the rapid adoption of highly processed, low-fiber diets. As Nigerians move away from traditional fiber-rich meals toward “Westernized” fast foods, gut inflammation and metabolic issues like insulin resistance have increased.

​Dr. Oyeleke also highlighted a specific cultural risk factor: high-temperature cooking. “Open-flame grilling, barbecuing, or smoking food at high temperatures produces harmful chemicals. When food is charred or burnt, it significantly increases cancer risk,” she warned.

​Symptoms You Must Not Ignore

​Because younger patients are often not suspected of having cancer, many dismiss early warning signs as common ailments. Experts urge the public to watch for:

1.Rectal Bleeding: Often mistaken for “piles” or jedi-jedi, persistent bleeding—especially when mixed with stool—is a major red flag.

ADVERTISEMENT

​2.Bowel Changes: Persistent constipation, diarrhea, or “pencil-thin” stools lasting several weeks.

​Unexplained Weight Loss: Dropping weight without changes in diet or exercise.

​3.Persistent Discomfort: Abdominal cramps, bloating, or the feeling that the bowel isn’t completely empty.

While the rise in cases is troubling, 2026 has brought a historic breakthrough for Nigerian patients. The Lagos University Teaching Hospital (LUTH), in collaboration with Medserve and Memorial Sloan Kettering Cancer Center, recently launched the nation’s first immunotherapy clinical trial for colorectal cancer.

​The trial, titled “PD-1 Blockade in Mismatch-Repair Deficient Colorectal Cancer,” targets a specific genetic subtype (dMMR) found in nearly 30% of Nigerian patients. Unlike traditional chemotherapy, which can be grueling, immunotherapy empowers the patient’s own immune system to recognize and destroy cancer cells.

​”This trial offers new hope for those with advanced stages of the disease,” notes Prof. Fatimah Abdulkareem of LUTH. “It brings cutting-edge, personalized medicine directly to Nigerian soil.”

​With the National Cancer Control Plan (2026–2030) now in motion, health advocates are pushing for earlier intervention. While international guidelines often suggest screening at 45, Nigerian specialists are increasingly advocating for average-risk individuals to begin screening at age 40, or even earlier if there is a family history of the disease.

​”Beyond stool tests, a colonoscopy remains the gold standard,” says Dr. Aje. “If we catch a polyp early and remove it, we don’t just treat cancer—we prevent it from ever starting.”